About Stasys
Stasys is a company based in Seattle (United States) founded in 2013 by Nathan White, Robert Barry, and Nate Sniadecki. Stasys has raised $2.85 million across 7 funding rounds from investors including HHS, DARPA and America’s Seed Fund. Stasys offers products and services including Atlas Platelet Strength Test and Shear Force Technology. Stasys operates in a competitive market with competitors including Hemosonics, HemoSense, Exactus, ClotChip and Atantares, among others.
- Headquarter Seattle, United States
- Founders Nathan White, Robert Barry, Nate Sniadecki
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stasys Medical Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.85 M (USD)
in 7 rounds
-
Latest Funding Round
$1.11 M (USD), Grant
Apr 19, 2021
-
Investors
HHS
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stasys
Stasys offers a comprehensive portfolio of products and services, including Atlas Platelet Strength Test and Shear Force Technology.
Rapid test measures platelet strength in blood to predict bleeding risks.
Enables reagent-free platelet activation for quick clinical assessments.
Funding Insights of Stasys
Stasys has successfully raised a total of $2.85M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.11 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Stasys
Stasys has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, DARPA and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in Washington-based startups by WRF Capital.
|
Locked | Locked | Locked |
Investor details for Stasys
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stasys
Investment portfolio details for Stasys
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stasys
Detailed financials for Stasys
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stasys Comparisons
Peer comparison for Stasys
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stasys
Stasys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemosonics, HemoSense, Exactus, ClotChip and Atantares, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
IVD for hemostasis characterization
|
|
| Locked | Locked | Locked |
Rapid Point-of-Care Coagulation analyzer
|
|
| Locked | Locked | Locked |
POC diagnostics for fibrinolytic status assessment are developed.
|
|
| Locked | Locked | Locked |
Portable tests for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies
|
Detailed competitors of Stasys
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stasys
Complete news archive for Stasys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stasys
Stasys was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Stasys is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Michael Rackley is the current CEO of Stasys.
Stasys is a funded company, having raised a total of $2.85M across 7 funding rounds to date.
Stasys was founded in 2013 in Seattle, United States, as a medical device company focused on hematology and trauma care. A point-of-care device is being developed to identify trauma-induced coagulopathy, which causes uncontrolled bleeding in patients. The technology analyzes clotting disorders and platelet function to support rapid diagnosis in clinical settings. Operations center on device innovation for emergency medical applications.
Stasys's top competitors include Hemosonics, Perosphere Technologies and Atantares.
Stasys offers Atlas Platelet Strength Test and Shear Force Technology.
Stasys has 7 investors. Key investors include HHS, DARPA, America’s Seed Fund, The W Fund, and WRF Capital.